Previous 10 | Next 10 |
Gainers: [[ISBC]] +13.2%. [[RDUS]] +8.6%. [[SRGA]] +8.5%. [[ARAY]] +8.3%. [[GOOG]] +7.8%.Losers: [[TENB]] -10.6%. [[VYGR]] -6.3%. [[TLSA]] -5.3%. [[EVLO]] -4.6%. [[RAIL]] -4.5%. For further details see: ARAY, GOOG, TENB and RDUS among after-hours movers
The following slide deck was published by Radius Health, Inc. in conjunction with this event. For further details see: Radius Health (RDUS) Presents At 39th Annual J.P. Morgan Healthcare Conference
Radius Health announces the acquisition of the development and commercialization rights for RAD011 from Benuvia Therapeutics. The deal economics appear favorable and should add to the top-line growth outlook while also offering diversification benefits. Alongside the M&A annou...
BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Kelly Martin, President and CEO will present a virtual corporate update at the 39 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13 at 9:10 a.m. EST....
Radius Health (RDUS) inks agreement to acquire the global development and commercialization rights to Benuvia Therapeutics' synthetic cannabidiol oral solution (RAD011).The Company plans to initiate a Phase 2/3 study for patients with Prader-Willi syndrome ((PWS)) in H2 2021 pending regulator...
RAD011 is a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseases Prader-Willi syndrome (“PWS”) will be the initial indication, which has been granted Orphan Drug and Fast Track Designation ...
Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada PR Newswire DUBLIN , Jan. 5, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited ...
Radius Health (RDUS) inks agreements with Endo International (ENDP), to register, commercialize, and distribute abaloparatide on an exclusive basis in Canada.Paladin Labs, an operating company of Endo, will be responsible for all commercial activities.Under the terms of the agreements, Paladi...
Agreement incorporates TYMLOS ® and abaloparatide-TD Consideration includes upfront payment, milestones based on clinical, regulatory and commercial progression, as well as royalties Key first step in expanding the global footprint for the abaloparatide asset beyond the...
BOSTON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) announced today that Machelle Sanders and Dr. Andrew C. von Eschenbach have joined the Company’s board of directors. Ms. Sanders and Dr. von Esche...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...